Keywords: Glucocerebrosidase deficiency; Lysosomal storage disease; Resting energy expenditure; Insulin resistance; High-density lipoprotein cholesterol; Hepatocellular carcinoma; Gaucher disease; ApoAI; apolipoprotein AI; ApoB; apolipoprotein B; ApoE; apolipoprote
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Plasma fatty acids; Adiposity; Cardiometabolic profile; Weight loss; Obese adolescents; apoA1; apolipoprotein A1; apoB; apolipoprotein B; BMI; body mass index; CRP; C-reactive protein; CVD; cardiovascular diseases; DBP; diastolic blood pressure; DHA; doco
Keywords: Familial hypercholesterolemia; FH; Universal screening; Cascade screening; Children; Cholesterol; Hypercholesterolemia; Next-generation sequencing; Genotype; LDLR; APOB; PCSK9;
Keywords: adolescent; type 2 diabetes mellitus; lipids; insulin; inflammatory markers; apoB; Apolipoprotein B; BMI; Body mass index; HbA1c; Glycated hemoglobin A1c; HDL-C; High-density lipoprotein cholesterol; hs-CRP; High-sensitivity C-reactive protein; IL-6; Inte
Keywords: 8-OHdG; 8-hydroxy-2-deoxyguanosine; Îym; mitochondrial membrane potential; AMPK; AMP-activated protein kinase; apoB; apolipoprotein B; AST; aspartate transaminase; ALT; alanine transaminase; ATP; adenosine triphosphate; CPT-1; carnitine palmitoyl-transfe
Keywords: apoA-I; apolipoprotein A-I; apoB; apolipoprotein B; apoE; apolipoprotein E; ABCA1; ATP-cassette binding transporter A1; ABCG1; ATP-cassette binding transporter G1; ACAT; acyl CoA cholesterol acyl transferase; ATP; adenosine triphosphate; CAD; coronary art
Keywords: Butein (PubChem CID: 5281222); Cardamonin (PubChem CID: 641785); 2â²,4â²-Dihydroxy-6â²-methoxy-3â²,5â²-dimethylchalcone (PubChem CID: 10424762); Flavokawain B (PubChem CID: 5356121); Hydroxysafflor Yellow A (PubChem CID: 6443665); Naringenin Chalcone
Keywords: ApoB; Apolipoprotein B; BMI; Body mass index; CRP; C-reactive protein; CCS; Canadian Cardiovascular Society; CV; Cardiovascular; CVD; Cardiovascular disease; CTT Collaboration; Cholesterol Treatment Trialists'; CIs; Confidence intervals; CHD; Coronary hea
Keywords: Cholesterol efflux capacity; Fatty Liver Index; HDL cholesterol; hsCRP; Metabolic syndrome; Non-alcoholic fatty liver disease; Type 2 diabetes mellitus; ApoA-I; apolipoprotein A-I; apoB; apolipoprotein B; ALT; alanine aminotransferase; AST; aspartate amin
Keywords: 18S; 18S ribosomal RNA; 36B4; acidic ribosomal protein 36B4; Acc1; acetyl-CoA carboxylase α; Acox1; acyl-CoA oxidase 1; Apob; apolipoprotein B; ARE; antioxidant response element; AST; aspartate aminotransferase; ALT; alanine aminotransferase; ATF4; activ
Keywords: Alirocumab; Hypercholesterolemia; LDLR; APOB; LDLRAP1;
Effects of a lupin protein concentrate on lipids, blood pressure and insulin resistance in moderately dyslipidaemic patients: A randomised controlled trial
Keywords: Lupin protein; Lipids; PCSK9; Blood pressure; Glycaemic control; ACE; angiotensin converting enzyme; ApoA-I; apolipoprotein A-I; ApoB; apolipoprotein B; BMI; body mass index; BP; blood pressure; CK; creatine kinase; CRP; C-reactive protein; CV; cardiovasc
Keywords: Plasma antioxidant vitamins; Plasma carotenoids; Cardio-metabolic profile; Weight loss; Obese adolescents; ApoA1; apolipoprotein A1; ApoB; apolipoprotein B; BMI; body mass index; CRP; C-reactive protein; CVD; cardiovascular diseases; DBP; diastolic blood
Keywords: Familial hypercholesterolemia; LDLR; APOB; PCSK9 gene mutations; Genotype-phenotype correlation; Mutation clusters;
Keywords: children; familial hypercholesterolemia; screening; LDL receptor gene; Genetics; ApoB; Apolipoprotein B; ASCVD; Atherosclerotic cardiovascular disease; BMI; Body mass index; DLCN; Dutch Lipid Clinic Network; EAS; European Atherosclerosis Society; FH; Fami
Keywords: ABCA1; ATP-binding cassette 1; AGEs; advanced glycation end products; AIF; apoptosis inducing factor; ALDH; aldehyde deshydrogenase; ANT; adenine nucleotide translocator; APAF1; apoptosis protease-activating factor-1; apoB; apolipoprotein B; ARE; antioxid
Keywords: AdoMet; S-adenosyl methionine; apoB; qapolipoprotein B; CK; choline kinase; CT; CTP:phosphocholine cytidylyltransferase; CPT; CDP-choline:1,2-diacylglycerol cholinephosphotransferase; CEPT; CDP-choline:1,2-diacylglycerol choline/ethanolamine phosphotransf
Keywords: Familial hypercholesterolemia; LDLR gene; Cholesterol; Genetic variants; Mutations; APOB; Cardiovascular disease prevention; Argentina; Cardiovascular disease; Public health;
Keywords: Familial hypercholesterolemia; Mutation spectrum; LDLR; APOB; PCSK9;
Keywords: Hypercholesterolemia; Genetics; Cardiovascular; PCSK9; Clinical trial; LDLR; APOB;
Keywords: ACC; acetyl-CoA carboxylase; ApoB; apolipoprotein B; ApoCII; apolipoprotein C-II; APPL-1; adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and a leucine zipper motif; CD36; fatty acid translocase; CETP; cholesteryl est
Keywords: LSD; lysosomal storage disease; CNS; central nervous system; BBB; blood-brain barrier; ERT; enzyme replacement therapy; GAG; glycosaminoglycans; CSF; cerebrospinal fluid; FDA; food and drug administration; ICV; intracerebroventricular; HLA; human leukocyt
Keywords: FH; familial hypercholesterolemia; SNP; single nucleotide polymorphism; PCSK9; protein convertase subtilisin/kexin 9 gene; APOB; apolipoprotein B gene; Familial hypercholesterolemia; LDLR mutation; LDL-C gene score;
Keywords: Familial hypercholesterolemia; Clinical criteria; Coronary artery disease; LDLR; APOB;
Keywords: atherosclerotic cardiovascular disease; cholesterol; primary prevention; secondary prevention; statins; triglycerides; ACC/AHA; American College of Cardiology/American Heart Association; apoB; apolipoprotein B; ASCVD; atherosclerotic cardiovascular diseas
Keywords: APOB; Familial hypercholesterolemia; Genetics; Greek; LDLR; Mutations; PCSK9;
Keywords: Lipid emulsion; Parenteral nutrition; Fatty acids; Lipid profile; Oxidative stress; ALA; α-linolenic acid; ApoaI; apolipoprotein aI; Apob; apolipoprotein b; ARA; arachidonic acid; BUN; blood urea nitrogen; Cr; creatinine; DHA; docosahexaenoic acid; EN; e
Keywords: Reference intervals; LIFE-Child; Serum lipids; Total cholesterol; Triglycerides; HDL; LDL; ApoA1; ApoB; Prevalence dyslipidemia
Keywords: coronary artery disease; gene sequencing; genetics; low-density lipoprotein cholesterol; APOB; apolipoprotein B; CAD; coronary artery disease; CI; confidence interval; FH; familial hypercholesterolemia; LDL; low-density lipoprotein; LDLR; low-density lipo
Keywords: APOB; apolipoprotein B; APOC3; apolipoprotein C3; ATGL; adipocyte triglyceride lipase; CGI-58; 1-acylglycerol-3-phosphate O-acyltransferase ABHD5; ENPP1; ectonucleotide pyrophosphate phosphodiesterase-1; FATP5; fatty acid transport protein 5; FFA; free fa
Keywords: Cholesterol; Biomarker; Multiple sclerosis; Clinically isolated syndrome; Apolipoprotein; ApoA; ApoB; ApoD; ApoE; Lipoprotein; LDL; HDL; Oxysterol; 24-hydroxycholesterol;
Keywords: ACC/AHA; American College of Cardiology/American Heart Association; ApoB; apolipoprotein B; ASCVD; atherosclerotic cardiovascular disease; CHD; coronary heart disease; DLCN; Dutch Lipid Clinic Network; FAMCAT; an FH prediction model; FDA; Food and Drug Ad
Keywords: apoA-1; apolipoprotein A-1; apoB; apolipoprotein B-100; CEC; cholesterol efflux capacity; CVD; cardiovascular disease; HDL; high-density lipoprotein; HOMA-IR; homeostasis model assessment of insulin resistance; LDL; low-density lipoprotein;
Keywords: Riesgo cardiovascular; Objetivos LDL; Apolipoproteína B (ApoB); Colesterol no-HDL; TratamientoCardiovascular risk; LDL objectives; ApoB; Non-HDL-cholesterol; Management
Keywords: Non-alcoholic fatty liver; Lipogenesis; Lipid secretion; Homocysteine; Sulfur-containing amino acid metabolism; ACC; acetyl-CoA carboxylase; AMPK; adenosine monophosphate-activated protein kinase; ApoB; apolipoprotein B; BHMT; betaine-homocysteine methy
Keywords: CVD; cardiovascular disease; CHD; coronary heart disease; MetS; metabolic syndrome; TLC; therapeutic lifestyle changes; BMI; body mass index; SBP; systolic blood pressure; DBP; diastolic blood pressure; Total-C; total cholesterol; LDL-C; low-density lipop
Keywords: Familial hypercholesterolemia; Diagnostic tools; Functional assay; Mutation pathogenicity; LDLR; APOB; PCSK9; ADH; autosomal dominant hypercholesterolemia; FH; familial hypercholesterolemia; LDLR; LDL receptor; APOB; apolipoprotein B-100; PCSK9; proprotei
Keywords: AHA; American Heart Association; ALT; Alanine aminotransferase; apoA1; Apolipoprotein A-1; apoB; Apolipoprotein B; AST; Aspartate aminotransferase; CHD; Coronary heart disease; CK; Creatine kinase; DHEA-S; Dehydroepiandrosterone sulphate; EC; Ethics Commi
Keywords: ApoB; apolipoprotein B; DAPI; 4',6-diamidino-2-phenylindole; DNase-1; deoxyribonuclease-1; ET; extracellular trap; MPO; myeloperoxidase;
Keywords: CAD; coronary artery disease; CVD; cardiovascular disease; TC; total cholesterol; HDL-C; high-density lipoprotein cholesterol; LDL-C; low density lipoprotein cholesterol; TG; triglycerides; ApoAI; apolipoprotein AI; ApoB; apolipoprotein B; Lp(a); lipoprot
Keywords: Nasal mucus; proteome; proteomics; allergic rhinitis; mass spectrometry; A2M; α2-Macroglobulin; APOA1; Apolipoprotein A-1; APOA2; Apolipoprotein A-2; APOA4; Apolipoprotein A-4; APOB; Apolipoprotein B-100; BPIFA1; BPI fold-containing family A member 1;
Keywords: Typical proprotein convertase; Prodomain; Furin; ApoB; HDL; VLDL; Atherosclerosis; Vascular remodeling;
Keywords: ABCA1; ATP-binding cassette transporter, subfamily A, member 1; ACC; American College of Cardiology; ADA; American Diabetes Association; AHA; American Heart Association; apoA1; apolipoprotein A1; apoB; apolipoprotein B; apoCIII; apolipoprotein CIII; BAS;
Keywords: ACCα; acetyl-CoA carboxylase α; ACTB; β actin; ADIPOR2; adiponectin receptor 2; AMPKα; adenosine monophosphate activated protein kinase α; APOB; apolipoprotein B; CORT; corticosterone; CPT1α; carnitine palmitoyltransferase 1α; FASN; fatty acid synt
Keywords: Ox-LDL; Oxidized low-density lipoprotein; HSP; Heat shock proteins; Tregs; Regulatory T cells; TGF-β; Transforming growth factor β; IL; Interleukin; ApoB; Apolipoprotein B; Cpn; Chlamydia pneumonia; DSP; Dendroaspin; GST; Glutathione S-transferase; IFN;
Keywords: Enterocyte; Plasma Lipid; Fatty Acid; Human Trial; ANOVA; analysis of variance; apoB; apolipoprotein B; AUC0-3; area under the concentration curve in the first 3 hours after treatment; BMD; bone mineral density; DPP-IV; dipeptidyl peptidase IV; FCR; fra
Keywords: AAV1; adeno-associated virus serotype 1; ACC; American College of Cardiology; ACCELERATE; A Study of Evacetrapib in High-Risk Vascular Disease; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADA; American Diabetes Association; AMP; adenosine m
Keywords: Metabolic syndrome; Apolipoproteins; Postprandium; Triglyceride; Chylomicrons; ApoB; apolipoprotein B; Chol; cholesterol; HDL-C; high density lipoproteins cholesterol; MetS; metabolic syndrome; SFA; saturated fatty acids; SNP; single nucleotide polymorphi
Keywords: TC; total cholesterol; RSD; Relative standard deviations; LDL-C; low density lipoproteins cholesterol; TG; triglyceride; HDL-C; high density lipoproteins cholesterol; CHD; coronary heart disease; Lp; lipoprotein; BMI; body mass index; ApoA; apolipoprotein
Keywords: NCEP; National Cholesterol Education Program; ATP; Adult Treatment Panel; LDL-C; low-density lipoprotein cholesterol; apoB; apolipoprotein B; VLDL; very low-density lipoprotein; IDL; intermediate-density lipoprotein; HDL-C; high-density lipoprotein, TG, t